These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 6733707

  • 21. [The Soviet cytostatic preparation prospidin in the therapy of malignant reticulohemoblastosis].
    Kalamkarian AA.
    Vestn Dermatol Venerol; 1978 Jun; (6):3-7. PubMed ID: 354247
    [No Abstract] [Full Text] [Related]

  • 22. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N, Tahara M, Kadowaki S, Fuse N, Doi T, Minami H, Ohtsu A.
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study.
    Conroy JF, Blessing JA, Kessinger A, Homesley HD.
    Cancer Treat Rep; 1984 Feb; 68(2):439-40. PubMed ID: 6697335
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
    Hussain M, Gadgeel S, Kucuk O, Du W, Salwen W, Ensley J.
    Cancer; 1999 Dec 01; 86(11):2364-9. PubMed ID: 10590379
    [Abstract] [Full Text] [Related]

  • 28. Locoregional effects of pegylated liposomal doxorubicin (Caelyx) in irradiated area: a phase I-II study in patients with recurrent squamous cell carcinoma of the head and neck.
    Faivre S, Alsabe H, Djafari L, Janot F, Julieron M, Domenge C, Djazouli K, Armand JP, Luboinski B, Raymond E.
    Eur J Cancer; 2004 Jul 01; 40(10):1517-21. PubMed ID: 15196535
    [Abstract] [Full Text] [Related]

  • 29. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.
    Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA.
    J Clin Oncol; 2004 Jan 15; 22(2):262-8. PubMed ID: 14722034
    [Abstract] [Full Text] [Related]

  • 30. Phase II study of rubitecan in recurrent or metastatic head and neck cancer.
    Caponigro F, Cartenì G, Droz JP, Milano A, Davis WB, Pollard P.
    Cancer Chemother Pharmacol; 2008 Jul 15; 62(2):209-14. PubMed ID: 17882418
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Long-term survival following salvage reirradiation with concurrent chemotherapy for recurrent head and neck cancer.
    Watkins JM, Stuart RK, Davis BK, Day TA, Chaudharry UB, Sharma AK.
    J S C Med Assoc; 2008 Feb 15; 104(2):36-9. PubMed ID: 18396601
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.
    Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randlev B, Gillenwater AM, Bruso P, Kaye SB, Hong WK, Kirn DH.
    Nat Med; 2000 Aug 15; 6(8):879-85. PubMed ID: 10932224
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Use of prospidin in the combination chemotherapy of recurrences of generalized forms of lymphogranulomatosis].
    Vinokurova NA, Danova LA, Kondrat'ev VB, Gershanovich ML.
    Vopr Onkol; 1983 Aug 15; 29(7):46-50. PubMed ID: 6880132
    [Abstract] [Full Text] [Related]

  • 40. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.
    Ratanatharathorn V, Drelichman A, Sexon-Porte M, Al-Sarraf M.
    Am J Clin Oncol; 1982 Feb 15; 5(1):29-32. PubMed ID: 6896258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.